# A Bioinformatics View of Glycan–Virus Interactions

Philippe Le Mercier, Julien Mariethoz, Josefina Lascano-Maillard, François

Bonnardel, Anne Imberty, Sylvie Ricard-Blum, Frédérique Lisacek

<figure><img src="image_1.png" /></figure>

## To cite this version:

Philippe Le Mercier, Julien Mariethoz, Josefina Lascano-Maillard, François Bonnardel, Anne Imberty, et al.. A Bioinformatics View of Glycan-Virus Interactions. Viruses, 2019, 11 (4), pp.374. 10.3390/v11040374. [https://hal.science/hal-02109612](https://hal.science/hal-02109612)

HAL Id: hal-02109612

https://hal.science/hal-02109612

Submitted on 6 Nov 2020

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_2.png" /></figure>
<figure><img src="image_3.png" /></figure>

Review

# A Bioinformatics View of Glycan–Virus Interactions

Philippe Le Mercier<sup>1,* ID</sup>, Julien Mariethoz<sup>2,3 ID</sup>, Josefina Lascano-Maillard<sup>2,3</sup>,
François Bonnardel<sup>2,3,4</sup>, Anne Imberty<sup>4 ID</sup>, Sylvie Ricard-Blum<sup>5 ID</sup> and
Frédérique Lisacek<sup>2,3,6,* ID</sup>

Received: 5 March 2019; Accepted: 15 April 2019; Published: 23 April 2019

<figure><img src="image_4.png" /></figure>

check for
updates

**Abstract:** Evidence of the mediation of glycan molecules in the interaction between viruses and their hosts is accumulating and is now partially reflected in several online databases. Bioinformatics provides convenient and efficient means of searching, visualizing, comparing, and sometimes predicting, interactions in numerous and diverse molecular biology applications related to the -omics fields. As viromics is gaining momentum, bioinformatics support is increasingly needed. We propose a survey of the current resources for searching, visualizing, comparing, and possibly predicting host-virus interactions that integrate the presence and role of glycans. To the best of our knowledge, we have mapped the specialized and general-purpose databases with the appropriate focus. With an illustration of their potential usage, we also discuss the strong and weak points of the current bioinformatics landscape in the context of understanding viral infection and the immune response to it.

**Keywords:** glycan; carbohydrate; bioinformatics; host-virus interactions; immunology; database; data integration; interoperability

## 1. Introduction

Viruses are genetic mobile elements that replicate into a host cell and produce viral particles to infect new cells or organisms. The virion journey in the extracellular space is an opportunity to interact in many ways with one of the most abundant molecules in that area: glycans. These multifunctional molecules cover most of epithelial or bacterial cells in a thick layer, called glycocalyx [1], or as soluble macromolecules called mucins [2]. In turn, numerous proteins are expressed at the surface of eukaryotic cells or viruses that bind those glycans. The glycocalyx can be a barrier for viruses that target cellular membranes [3,4], but also an opportunity to bind specific targets for virus replication [5].

These host-virus interactions are dynamic and multifaceted. Some viruses have evolved to bind specific glycans in order to infect cells, like human rotaviruses binding to blood group A antigens [6]. Infecting cells has consequences, and the immune system is able to recognize some virions through their glycans. This is the case of macrophages or dendritic cells that phagocyte virions through binding glycans at their surface as observed in HIV (Human Immunodeficiency Virus) [7], Ebola virus [8], HCV (Hepatitis C virus) [9], as well as the influenza [10] or SARS (Severe Acute Respiratory Syndrome)

<footnote n="1">1 Swiss-Prot Group, SIB Swiss Institute of Bioinformatics, 1211 Geneva, Switzerland</footnote>

<footnote n="2">2 Proteome Informatics Group, SIB Swiss Institute of Bioinformatics, 1211 Geneva, Switzerland; julien.mariethoz@sib.swiss (J.M.); Josefina.LascanoMaillard@unige.ch (J.L.-M.); francois.bonnardel@cermav.cnrs.fr (F.B.)</footnote>

<footnote n="3">3 Computer Science Department, University of Geneva, 1227 Geneva, Switzerland</footnote>

<footnote n="4">4 Université Grenoble Alpes, CNRS, CERMAV, 38041 Grenoble, France; anne.imberty@cermav.cnrs.fr</footnote>

<footnote n="5">5 Institut de Chimie et Biochimie Moléculaires et Supramoléculaires, UMR 5246 CNRS—Université Lyon 1, 69622 Villeurbanne Cedex, France; sylvie.ricard-blum@univ-lyon1.fr</footnote>

<footnote n="6">6 Section of Biology, University of Geneva, 1211 Geneva, Switzerland</footnote>

<footnote>* Correspondence: philippe.lemercier@sib.swiss (P.L.M.); frederique.lisacek@sib.swiss (F.L.); Tel.: +41-22-379-5050 (P.L.M. & F.L.)</footnote>
viruses [11]. In turn, this anti-viral system is exploited by several viruses that target macrophages or dendritic cells for their replication, like the Ebola virus [8] and SARS virus [11]. Another unexpected role of host glycans is to evade immune system recognition of viral molecules. By having their virion surface proteins covered with host glycans, specific viral epitopes are physically hidden under neutral host molecules and cannot be recognized by immune cells. This effect is referred as to the glycan shield and the best example of this feature are the HIV virus, known to have the highest density of glycans attached to its surface proteins [12], and the Lassa virus [13].

All of these functions are critical for viral replication of most pathogenic viruses and could be exploited to create antiviral compounds [14]. Nonetheless this remains a challenge because of the complexity of these interactions involving diverse host-virus hybrid molecules. The cellular machinery produces numerous sugars that can be combined into a broad variety of glycosylation types, allowing an extended heterogeneity of virion surface molecules. Studying such multifaceted interplay between glycans and viruses results in complex data that cannot be thoroughly understood without databases and bioinformatics [15]. The interpretation of large-scale analyses depends on comparative and predictive approaches in which biological databases play a crucial role. This emphasizes the importance of collecting, storing, curating, and making these data searchable online. Next, crosslinking the various specialized databases brings the user a broader view to grasp the complexity of multi-organism interactions. In the present review, we suggest that bioinformatics and databases are key to harnessing the potential for new knowledge discovery in virus and vaccine research. We also show that integrating complementary information from multiple sources is not straightforward.

## 2. The Current Landscape of Bioinformatics Resources for Molecular Glycovirology

### 2.1. Overview

A handful of bioinformatics resources include the relevant pieces of information that can be put together to study glycan-virus interactions at different stages of infection. To follow the outline of a recent review highlighting the roles of glycosylation in virus biology [16], we have mapped the corresponding databases as shown in Figure 1. Overall, these roles pertain to immunity, attachment, entry, and exit, as well as glycoprotein synthesis.

ViralZone [17] is a web resource that bridges sequence data to virus knowledge thereby providing the means of exploring the diversity of viruses. It links to viral proteome sequences contained in UniProtKB [18], the Universal Protein Knowledgebase. UniProtKB is also a reliable source for describing host glycoproteins that are further characterized in neXtProt [19] when the host is human. Irrespective of their origin, knowledge of glycoproteins and the glycans they carry is stored in GlyConnect [20].

In fact, most viruses use the host glycosylation machinery composed of enzymes that are categorized in the CAZy database of Carbohydrate-Active enZymes [21] upon sequence similarity and biosynthetic or degrading activity. Glycans are the substrates and products of these reactions. GlyTouCan [22] is the most comprehensive glycan structure repository.
<figure><img src="image_5.png" /><figcaption>**Figure 1.** Virus interaction with glycans mapped with corresponding bioinformatics resources.</figcaption></figure>

ViralZone, includes detailed information on virus taxonomy, virion structures, as well as their interactions with other molecules. This latter aspect highlights the frequent occurrence of glycan mediation in receptor binding. This is shown, for example, with cross-references to SugarBindDB [23] that collects information regarding host surface glycan recognition by pathogenic agents such as viruses. Other instances of viral protein recognition via heparan sulfate proteoglycan (co)-receptors are cited in ViralZone though do not yet referr to MatrixDB [24], a database that maps experimentally proven interactions between ECM (extracellular matrix) proteins, proteoglycans, and glycosaminoglycans (GAGs). More generally, carbohydrate-binding proteins of all origins are compiled and classified in UniLectin [25], a recently released platform for the study of lectins.

Major molecules involved in immunity (antibodies and antigens) are extensively covered in two very popular and long-standing databases, namely: the International Immuno-Genetics information system (IMGT) [26] and the Immune Epitope Database (IEDB) [27]. More recently, a Database of Anti-Glycan Reagents (DAGR) [28] focused on anti-glycan antibodies was launched. Unfortunately, DAGR is currently devoid of any cross-reference to existing databases. In fact, the obvious advantage of mapping the resources in relation to virus cycle as shown in Figure 1, is to emphasize the potential for exploring knowledge via cross-references. The connectivity of databases is shown in Figure 2 where the renowned UniProtKB and Protein Data Bank (PDB) [29] obviously play a central role. As such, they provide general knowledge that can then be refined through consulting the more specialized resources featured in the figure. The content description and relevance to virology of each resource featuring in Figure 2 are provided in Table 1. The creation date was added as an indication of not only the reliability of sources, such as UniProtKB, PDB and IMGT, but also the profusion of recent effort in glycoinformatics.
<figure><img src="image_6.png" /><figcaption>**Figure 2.** One- or two-way referencing between online databases. Arrows represent links between different resources and are double edged if links are reciprocal. Blue dotted lines represent future links that will strengthen the framework of databases.</figcaption></figure>

Note that each and every of these resources is pointing to PubMed [30], the biomedical literature search engine that provides access to bibliographic information. This systematic link is not pictured to avoid crowding the figure with arrows, nonetheless the existence of shared PubMed IDs between databases is an asset for knowledge mining. We illustrate this point with PubMed ID 12825167 [31] that is common between UniProtKB and SugarBindDB. A scenario of navigation across databases is shown in Figure 3.

<figure><img src="image_7.png" /><figcaption>**Figure 3.** Example of exploration via cross-references.</figcaption></figure>
<table><caption>**Table 1.** The databases pictured in Figure 2 are briefly described and qualified for their relevance to virology.</caption><thead><tr><th>Name</th><th>URL</th><th>Main Content</th><th>Relevance to Virology</th><th>Example of Use</th><th>Data Status</th><th>Created in</th><th>Reference</th></tr></thead><tbody><tr><td>ViralZone</td><td>viralzone.expasy.org</td><td>Illustrated encyclopedia of viruses</td><td>Links textbook knowledge to sequence data</td><td>Explore the specific molecular biology of a virus</td><td>Curated</td><td>2008</td><td>[17]</td></tr><tr><td>UniProt</td><td>www.uniprot.org</td><td>Integrated knowledge of proteins</td><td>Provides protein sequence and functional information.</td><td>Find glycosylation sites in protein sequence</td><td>Curated (Swiss-Prot section)</td><td>1986</td><td>[18]</td></tr><tr><td>neXtprot</td><td>www.nextprot.org</td><td>Integrated knowledge of human proteins</td><td>Provides detailed functional information on human proteins</td><td>Characterize human host surface receptors</td><td>Partially curated</td><td>2009</td><td>[19]</td></tr><tr><td>PDBe</td><td>www.ebi.ac.uk/pdbe</td><td>3D structures of proteins</td><td>Structural virology: capsid structures, host-virus interactions.</td><td>Examine the 3D structure of a capsid protein</td><td>Partially curated</td><td>1980</td><td>[29]</td></tr><tr><td>ChEBI</td><td>www.ebi.ac.uk/chebi</td><td>Information on chemical compounds</td><td>Describes chemical compounds interacting with viruses</td><td>Explore the molecule formula of a given compound</td><td>Curated</td><td>2004</td><td>[32]</td></tr><tr><td>PubChem</td><td>pubchem.ncbi.nlm.nih.gov</td><td>Information on chemical compounds and corresponding assays</td><td>Collects assays involving chemical compounds interacting with viruses</td><td>Find binding assays associated with a virus</td><td>Minimally curated</td><td>2004</td><td>[33]</td></tr><tr><td>CAZy</td><td>www.cazy.org</td><td>Carbohydrate Active Enzymes (CAZymes)</td><td>Families of viral CAZymes</td><td>Find viral CAZymes and associated Enzyme Nomenclature numbers</td><td>Curated</td><td>1998</td><td>[21]</td></tr><tr><td>GlyTouCan</td><td>www.glytoucan.org</td><td>Glycan 2D structures</td><td>Provides information on glycan structure.</td><td>Check existence of glycan bound by virus</td><td>Not curated</td><td>2016</td><td>[22]</td></tr><tr><td>Rhea</td><td>www.rhea.org</td><td>Enzymatic reactions</td><td>Describes virus specific enzyme reactions</td><td>Find substrate and product of CAZyme reaction</td><td>Curated</td><td>2011</td><td>[34]</td></tr><tr><td>MatrixDB</td><td>matrixdb.univ-lyon1.fr</td><td>Extracellular matrix components and interactions</td><td>Describes glycosaminoglycans and their interactions</td><td>Find interactions involving heparan sulfate</td><td>Curated</td><td>2008</td><td>[24]</td></tr><tr><td>SugarBind</td><td>sugarbind.expasy.org</td><td>Host glycans and pathogen lectins</td><td>Describes glycan-virus interactions</td><td>Explore pathogen lectins/adhesins binding a glycan motif</td><td>Curated</td><td>2005</td><td>[23]</td></tr><tr><td>UniLectin3D</td><td>www.unilectin.eu</td><td>Carbohydrate-binding proteins (not Ab)</td><td>Collects glycan-virus interactions</td><td>Inspect atomic details of glycan-haemagglutinin interactions</td><td>Curated</td><td>2018</td><td>[25]</td></tr><tr><td>GlyConnect</td><td>glyconnect.expasy.org</td><td>Integrated knowledge of glycoproteins</td><td>Describes glycoproteins</td><td>Find sialylated glycans on receptor proteins</td><td>Curated</td><td>2017</td><td>[20]</td></tr><tr><td>IMGT</td><td>www.imgt.org</td><td>Integrated knowledge of immunoglobulins</td><td>Collects antibody sequences and structures</td><td>Find antiviral antibody sequences</td><td>Curated</td><td>1989</td><td>[26]</td></tr><tr><td>IEDB</td><td>www.iedb.org</td><td>Collected knowledge of antigenic ligands (epitopes)</td><td>Collect experimental data characterizing the antigenicity of a virus.</td><td>Find viral antigenic peptides</td><td>Curated</td><td>2003</td><td>[27]</td></tr><tr><td>DAGR</td><td>ccr2.cancer.gov/resources/ Cbl/Tools/Antibody</td><td>Carbohydrate-binding antibodies</td><td>Collects anti-glycan reagents</td><td>Find glycan binding motifs of antiviral antibodies</td><td>Curated</td><td>2016</td><td>[28]</td></tr></tbody></table>
<table><caption>**Table 2.** The tools either used in the example of Figure 3 or mentioned in the text as known to visualize or analyze glycan-binding data are briefly described and qualified for their relevance to virology.</caption><thead><tr><th>Name</th><th>URL</th><th>Purpose</th><th>Applicable to Virology</th><th>Created in</th><th>Reference</th></tr></thead><tbody><tr><td>LiteMol</td><td>www.litemol.org</td><td>Visualization of protein 3D structure</td><td>yes</td><td>2015</td><td>[35]</td></tr><tr><td>GlyS<sup>3</sup></td><td>glycoproteome.expasy.org/substructuresearch</td><td>Glycan substructure search</td><td>yes</td><td>2015</td><td>[36]</td></tr><tr><td>GlycoPattern</td><td>glycopattern. memory.edu</td><td>Analysis of glycan array data</td><td>yes</td><td>2014</td><td>[37]</td></tr><tr><td>GLAD</td><td>glycotoolkit.com/GLAD</td><td>Visualization and analysis of glycan array data</td><td>yes</td><td>2019</td><td>[38]</td></tr><tr><td>Glycome Atlas</td><td>rings.t.soka.ac.jp/GlycomeAtlasV5/index.html</td><td>Visualization of glycan array data</td><td>no</td><td>2012</td><td>[39]</td></tr></tbody></table>
## 2.2. Illustration of Usage

The SugarBindDB entry for Norovirus Norwalk virus GrV (the official designation should be GV according to ViralZone but SugarBindDB reports the name found in the cited source) is associated with several glycan binders one of which being A type 1 A Lewis b (GalNAc(α1-3)[Fuc(α1-2)]Gal(β1-3)[Fuc(α1-4)] GlcNAc(β1-3)Gal), characterized in PubMed ID 12825167 [31]. This article is cited as well in the cross-referenced Norwalk virus capsid protein VP1 entry of UniProtKB (Q83884). Reciprocal links between SugarBindDB and ViralZone, as well as the common UniProtKB entry, provide alternative accesses to the general knowledge on Noroviruses described in ViralZone. This very same UniProtKB protein entry is also shared by UniLectin that classifies this carbohydrate-binding protein in the beta-sandwich/jelly roll category. Other viral lectins with this fold can be explored from there. UniProtKB and UniLectin both cross-link to PDB entries associated with capsid protein VP1, but the latter database favors PDB references with bound glycan ligands. This is the case of PDB 2ZL7 that details GalNAc(α1-3)[Fuc(α1-2)]Gal as a ligand. Note that PDB is preferred as it uses the LiteMol software [35] for visualizing 3D structures. LiteMol has a convenient app for showing glycan in 3D [40], consistent with the Symbol Nomenclature For Glycans (SNFG) notation [41] that is used in Figure 3 and in all glyco-related resources cited. Both glycan ligands proposed either in SugarBindDB or in UniLectin are matched to GlyConnect using GlyS³, an in-house substructure search engine [36] also available as a standalone tool from the Glycomics@ExPASy collection [42]. The result is a list of full glycan structures containing the ligand substructures. Most of these full structures are attached to mucins, some of which are linked to UniProtKB.

Another course of exploration can be followed through the reciprocal link between SugarBindDB and GlyTouCan. A type 1 A Lewis b is registered in GlyTouCan and the corresponding record includes a link to molecules in PubChem [33] which, as part of the large NCBI (National Center for Biotechnology Information) collection [30], opens many further lines of investigation.

This example illustrates the potential for identifying protein interacting partners along with details of the glycan structures and glycan ligands that mediate this interaction. If databases were to be more complete, automated procedures could rapidly extract the relevant pieces of information. At this stage, the proposed scenario can only be performed by a user clicking on available links.

## 3. Repertoire Mapping to Enrich Databases

A large part of the knowledge regarding glycan-virus interactions remains in the literature which is screened by database curators to be made available online. This is a slow process which mainly explains the current lacks in databases. Furthermore, this incomplete picture leads to focus on general-purpose resources such as UniProtKB or the PDB with PubMed in the background. Figure 2, where most arrows are concentrated on these resources, illustrates this point conclusively, as well as highlights the limited potential for glycan data integration in the immunological databases.

Substantial knowledge is also contained in the results of glycan arrays that have been used to study virus-host interactions for close to two decades. For instance, this approach revealed the subtle differences that distinguish avian from human flu based on glycan recognition by hemagglutinin [43]. There are a few online sources of data that have stored the results of glycan array screening. The one that has been considered for many years as the reference was the first online repository put together by the US-based Consortium for Functional Glycomics (CFG) [44]. However, due to the discontinuation of funding, it is no longer updated and only temporarily maintained. These data are still available for download on the CFG website (http://www.functionalglycomics.org/glycomics/publicdata/primaryscreen.jsp). Dedicated tools were also developed specifically for visualizing [39] or mining [37] the CFG array data. While the latter is also no longer maintained, the former does not include virus data. At this point in time, US-based glycan array data collecting and mining is in transition between old and new initiatives. As we write, a new platform designed to visualize, analyze and compare glycan microarray data is briefly introduced in a just released Application Note [38]. This shows that bioinformatics applied to processing and analyzing glycan array data is still very much in the making. Another reference library is hosted in the
Glycosciences Laboratory of Imperial College, London. It contains many virus screens (see Category D in https://glycosciences.med.ic.ac.uk/data.html). However, each experimental result displayed from the database does not provide any cross-reference other than a link of a cited published article to PubMed.

Table 2 summarizes information on the software tools that have been cited in the text so far, mainly for visualizing structural or glycan-binding data.

## 3.1. Glycans as Virus Receptors in ViralZone

Viruses initiate infection of a host cell by attaching to specific receptors. Binding to an entry receptor triggers a chain of dynamic events that will enable cell penetration by the virus. Many virus-host receptor interactions have been described, and those are reported in the ViralZone virus receptors table (https://viralzone.expasy.org/5356) which contains 254 expert curated interactions. An excerpt of this table is shown in Figure 4. Of those, 53 are interactions with glycans (carbohydrates) from 49 different viruses. All proteinaceous molecules are linked to UniProtKB, glycans are linked to small molecule entries of ChEBI [32] through Rhea, the biochemical reaction database [34] and to SugarBindDB. Representing glycan ligands bound by the influenza virus is challenging because it binds the sialic acid cap of those, and therefore can attach to many different molecules. The link to SugarBindDB provides a clean overview with the detailed structure of 92 agents bound by the influenza virus. On the other hand, ChEBI links provide the chemical structure of involved sialic acids. Bridging these resources allows investigators to browse freely toward different aspects of biology and chemistry and constitutes a substantial added value to the data.

<figure><img src="image_8.png" /><figcaption>**Figure 4.** Excerpt of the ViralZone virus receptor table (https://viralzone.expasy.org/5356). The screenshot displays the first four carbohydrate receptors of viruses.</figcaption></figure>

## 3.2. Emerging Knowledge in MatrixDB

The majority of interactions stored in MatrixDB involve proteins and proteoglycans and glycosaminoglycans. Numerous viruses (e.g., coronavirus, human papillomavirus virus, hepatitis B and C viruses, HIV, and Zika virus) use GAGs displayed at the surface of host cells, mostly heparan sulfate, for host cell attachment and invasion [45–48]. However, only one curated paper describes a GAG-virus receptor interaction between heparin and the Gibbon ape leukemia virus receptor 2 or sodium-dependent phosphate transporter 2 (Q08357) in MatrixDB, emphasizing the urgent need of curation. The corresponding UniProt entry states that “it functions as a retroviral receptor and confers human cells susceptibility to infection to amphotropic murine leukemia virus (A-MuLV),
10A1 murine leukemia virus (10A1 MLV) and some feline leukemia virus subgroup B (FeLV-B) variants" as supported by [49].

The field of glycosaminoglycanomics is budding, but data collection is still limited by the lack of standards to encode structural information [50]. Progress in complying with standards is the first step to increasing connectivity [51]. Furthermore, links between ChEBI and MatrixDB help bridging with chemical biology databases. GAG entries of MatrixDB are also cross-referenced with GlyTouCan.

MatrixDB is designed and built to display interaction networks that provide a snapshot of direct and indirect physical interactions between proteins, GAGs, and small molecules with a particular focus on the precise definition of extracellular matrix multimers. Ultimately, the table shown in Figure 4 will be refined to include links to MatrixDB, which in turn will share data with SugarBindDB.

### 3.3. *SugarBindDB and UniLectin as Key Connectors*

As visible in Figure 3, *SugarBindDB* and *UniLectin* are suitable connectors between virology, protein science, and chemical biology. This of course reflects the biological role of lectins as key players in cell-cell communication. Since *SugarBindDB* is dedicated to the characterization of pathogen lectins, it is naturally connected to ViralZone. *Unilectin* is by definition universal and collects data that cover all kingdoms. Since the intricate network of interactions at the host cell surface also involves host lectins recognizing pathogen glycans, a full description of the situation may require further data from *UniLectin*.

*UniLectin* includes *UniLectin3D*, which unsurprisingly compiles three-dimensional information regarding lectins and glycan ligands. In particular, some structures available in this database provide details of viruses binding to glycans of animal cell surfaces (rotavirus, influenza, etc.) and to bacterial cell walls (bacteriophage). In *Norovirus*, the capsid protein sequences differ among the several genotypes, resulting in a fine specificity for different human histo-blood groups. Figure 5 illustrates the tree-search for noroviruses together with selected structures of GI-7 genotype in complex with Lewis Y and blood group A tetrasaccharides as described in [52]. These screenshots also highlight the links with external databases, as well as the details of the cited publication that are available through the green box expansion.

<figure><img src="image_9.png" /><figcaption>**Figure 5.** Partial result of UniLectin3D search for Norovirus, with selected examples of entries of GI-7 genotype.</figcaption></figure>
As a final comment in this section, note that new virus-related entries in SugarBindDB are very slowly finding their way into the database due to the poor funding of biocuration. This raises the question of associating experts with the database development and is hardly a hidden invitation.

## 4. Discussion

Bioinformatics tools have become indispensable for processing and analyzing the now popular -omics data. Raw data associated with published articles are routinely submitted in repositories, while dedicated databases are developed to shape the implicit knowledge revealed in analyzed -omics data. Such a setup is now operational to support the enlightened interpretation of new results in genomics, transcriptomics, and proteomics, as well as to maximize data sharing, reuse, and integration. Based on this interoperability, a broad range of automated procedures are implemented to collect and piece together information from databases and support the formulation of new and testable hypotheses. At this stage, glycomics has not quite yet reached that level despite the essential roles of glycans in the mediation of molecular interactions. In the particular case of virology, this lack is visible.

The panoramic view of the different information resources covering interactions between virus and glycans as shown in Figure 2, should help to improve both the breadth and depth of knowledge. Obviously, the current connectivity between resources is far from being complete and new cross-links are needed for users to make the most of all data disseminated in several resources. We strive to fill that gap. As partially mentioned earlier, near future plans encompass new content in MatrixDB that will enable the creation of cross-links between SugarBindDB and MatrixDB, with a focus on GAG-binding pathogens. Furthermore, in order to make the substrates and products of enzymatic reactions collected in CAZy more explicit, substantial work on harmonizing knowledge representation is underway. This requires the inclusion of information from the Rhea database to generate the association of each known glycan structure of GlyConnect with its required enzyme toolbox. The main obstacle to this apparently straightforward application lies in the limitations in format sharing between chemical biology, carbohydrate chemistry, and glycobiology. Figure 6 illustrates the situation by highlighting format (in)compatibility between databases. The diversity of information sources is yet again creating barriers of communication. Standards such as SMILES (Simplified Molecular Input Line Entry Specification) and InChi (International Chemical Identifier) have been adopted in chemical biology and cheminformatics, while IUPAC (International Union of Pure and Applied Chemistry) remains the gold reference in biochemistry. Glycobiology has developed a series of encoding formats that were attempts in a variety of ways to account for the branched structures. In the end, the multiplicity is such that toolboxes of converters have been developed over the years [53,54]. Nonetheless, the (glyco-)bioinformatics community has opted for GlycoCT as a structure encoding format [55] shared by the majority of databases. Furthermore, it seems that SNFG [41] is spreading as a unique code for representing glycans. Despite growing consensus in each community for relying on shared standards, cross-talk is not established between disciplines, and requires the bridging tasks we have undertaken.

Moreover, there are missing data that would be very useful for virology. For example, tissue localization of various glycans in vertebrates would be invaluable to correlate with virus tissue infections. This kind of resource exists for proteins [56], but not yet for glycans.

Finally, a paradigm shift is also needed to advance the field of glycovirology. For example, a comprehensive survey of known glycosylation in *Mononegavirales* was recently published [57]. Had the authors known about ViralZone, the valuable though PDF-static information printed in this article could have been structured in a way to be stored straightaway in the database and enhance virus annotation. It takes bioinformaticians days of work to search the relevant information often hidden in supplementary material of published articles when simple awareness of reference online resources could suffice to motivate authors to disseminate their work through interacting upstream with database developers. For as long as automated data submission procedures are not imposed as they are now for DNA sequence or protein mass spectrometry data, glyco-viro-database improvement
relies on researchers' good will to actively share their data. With the present article, we wish to convey the advantages of increasing bioinformatics usage in glyco-virology and show how it reveals implicit correlations through searching cross-referenced resources. The more complete the stored data, the better the chances of unearthing gems.

<figure><img src="image_10.png" /><figcaption>**Figure 6.** Variety of (in)compatible molecule and reaction encoding formats associated with each database in each category (molecules/reactions/glycoconjugates) hindering smooth cross-referencing.</figcaption></figure>

**5. Conclusions**

Glycans are prevalent molecules that offer a broad range of interplay with viruses crossing the extracellular space to infect new cells. Bioinformatics resources are critical for the analysis of the diversity of available data. We have provided a broad overview of the bioinformatics landscape of glycan-virus interactions. This has fed a reflection and discussion on the need and the means of increasing interoperability between existing databases as a key to support interaction data interpretation. The next step is surely to focus on bridging more tightly immunology and glyco-virology resources.

**Author Contributions:** Methodology, P.LM., A.I., S.R-B., F.L.; software, J.M., F.B.; data curation, J.L-M.; writing—original draft preparation, P.LM., F.L.; writing—review and editing, all; funding acquisition, P.LM., A.I., S.R-B., F.L.

**Funding:** ViralZone is developed by the Swiss-Prot group and is supported by the Swiss Federal Government through the State Secretariat for Education, Research and Innovation (SERI), the National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI), and National Institute of General Medical Sciences (NIGMS) (grant U41HG007822), and the Swiss National Science Foundation (SNSF) (grant IZLSZ3_148802). The development of resources of the glycomics@ExPASy initiative has been supported by the European Union FP7 Innovative Training Network (grant 316929) and the Swiss Federal Government through the State Secretariat for Education, Research and Innovation (SERI) and are currently supported by the Swiss National Science Foundation (SNSF) (grant 31003A_179249). ExPASy is maintained by the web team of the Swiss Institute of Bioinformatics and hosted at the Vital-IT Competency Center. MatrixDB is supported by the Fondation pour la Recherche Médicale (grant DBI20141231336), and the Institut Français de Bioinformatique (call 2015). UniLectin is supported by ANR PIA Glyco@Alps (ANR-15-IDEX-02). Overall cooperation between groups is supported by the Alliance Campus Rhodanien Co-Funds (http://campusrhodanien.unige-cofunds.ch).

**Conflicts of Interest:** The authors declare no conflicts of interest.
References

1. Curry, F.E.; Adamson, R.H. Endothelial Glycocalyx: Permeability Barrier and Mechanosensor. *Ann. Biomed. Eng.* **2012**, *40*, 828–839. [CrossRef]

2. Linden, S.K.; Sutton, P.; Karlsson, N.G.; Korolik, V.; McGuckin, M.A. Mucins in the mucosal barrier to infection. *Mucosal Immunol.* **2008**, *1*, 183–197. [CrossRef]

3. Frey, A.; Giannasca, K.T.; Weltzin, R.; Giannasca, P.J.; Reggio, H.; Lencer, W.I.; Neutra, M.R. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: Implications for microbial attachment and oral vaccine targeting. *J. Exp. Med.* **1996**, *184*, 1045–1059. [CrossRef]

4. Stonebraker, J.R.; Wagner, D.; Lefensty, R.W.; Burns, K.; Gendler, S.J.; Bergelson, J.M.; Boucher, R.C.; O'Neal, W.K.; Pickles, R.J. Glycocalyx Restricts Adenoviral Vector Access to Apical Receptors Expressed on Respiratory Epithelium In Vitro and In Vivo: Role for Tethered Mucins as Barriers to Lumenal Infection. *J. Virol.* **2004**, *78*, 13755–13768. [CrossRef] [PubMed]

5. Olofsson, S.; Bergström, T. Glycoconjugate glycans as viral receptors. *Ann. Med.* **2005**, *37*, 154–172. [CrossRef]

6. Böhm, R.; Fleming, F.E.; Maggioni, A.; Dang, V.T.; Holloway, G.; Coulson, B.S.; von Itzstein, M.; Haselhorst, T. Revisiting the role of histo-blood group antigens in rotavirus host-cell invasion. *Nat. Commun.* **2015**, *6*, 5907. [CrossRef]

7. Celerino da Silva, R.; Segat, L.; Crovella, S. Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission. *Hum. Immunol.* **2011**, *72*, 305–311. [CrossRef] [PubMed]

8. Simmons, G.; Reeves, J.D.; Grogan, C.C.; Vandenberghe, L.H.; Baribaud, F.; Whitbeck, J.C.; Burke, E.; Buchmeier, M.J.; Soilleux, E.J.; Riley, J.L.; et al. DC-SIGN and DC-SIGNR Bind Ebola Glycoproteins and Enhance Infection of Macrophages and Endothelial Cells. *Virology* **2003**, *305*, 115–123. [CrossRef] [PubMed]

9. Lai, W.K.; Sun, P.J.; Zhang, J.; Jennings, A.; Lalor, P.F.; Hubscher, S.; McKeating, J.A.; Adams, D.H. Expression of DC-SIGN and DC-SIGNR on Human Sinusoidal Endothelium. *Am. J. Pathol.* **2006**, *169*, 200–208. [CrossRef] [PubMed]

10. Londrigan, S.L.; Turville, S.G.; Tate, M.D.; Deng, Y.-M.; Brooks, A.G.; Reading, P.C. N-Linked Glycosylation Facilitates Sialic Acid-Independent Attachment and Entry of Influenza A Viruses into Cells Expressing DC-SIGN or L-SIGN. *J. Virol.* **2011**, *85*, 2990–3000. [CrossRef] [PubMed]

11. Yang, Z.-Y.; Huang, Y.; Ganesh, L.; Leung, K.; Kong, W.-P.; Schwartz, O.; Subbarao, K.; Nabel, G.J. pH-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus Is Mediated by the Spike Glycoprotein and Enhanced by Dendritic Cell Transfer through DC-SIGN. *J. Virol.* **2004**, *78*, 5642–5650. [CrossRef]

12. Bonomelli, C.; Doores, K.J.; Dunlop, D.C.; Thaney, V.; Dwek, R.A.; Burton, D.R.; Crispin, M.; Scanlan, C.N. The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade. *PLoS ONE* **2011**, *6*, e23521. [CrossRef] [PubMed]

13. Watanabe, Y.; Raghwani, J.; Allen, J.D.; Seabright, G.E.; Li, S.; Moser, F.; Huiskonen, J.T.; Strecker, T.; Bowden, T.A.; Crispin, M. Structure of the Lassa virus glycan shield provides a model for immunological resistance. *Proc. Natl. Acad. Sci. USA* **2018**, *115*, 7320–7325. [CrossRef]

14. Shi, Q.; Wang, A.; Lu, Z.; Qin, C.; Hu, J.; Yin, J. Overview on the antiviral activities and mechanisms of marine polysaccharides from seaweeds. *Carbohydr. Res.* **2017**, *453–454*, 1–9. [CrossRef]

15. Greene, A.C.; Giffin, K.A.; Greene, C.S.; Moore, J.H. Adapting bioinformatics curricula for big data. *Brief. Bioinform.* **2016**, *17*, 43–50. [CrossRef]

16. Bagdonaite, I.; Wandall, H.H. Global aspects of viral glycosylation. *Glycobiology* **2018**, *28*, 443–467. [CrossRef] [PubMed]

17. Masson, P.; Hulo, C.; De Castro, E.; Bitter, H.; Gruenbaum, L.; Essioux, L.; Bougueleret, L.; Xenarios, I.; Le Mercier, P. ViralZone: Recent updates to the virus knowledge resource. *Nucleic Acids Res.* **2013**, *41*, D579–D583. [CrossRef] [PubMed]

18. UniProt Consortium. UniProt: The universal protein knowledgebase. *Nucleic Acids Res.* **2018**, *46*, 2699. [CrossRef] [PubMed]

19. Duek, P.; Gateau, A.; Bairoch, A.; Lane, L. Exploring the Uncharacterized Human Proteome Using neXtProt. *J. Proteome Res.* **2018**, *17*, 4211–4226. [CrossRef]
20. Alocci, D.; Mariethoz, J.; Gastaldello, A.; Gasteiger, E.; Karlsson, N.G.; Kolarich, D.; Packer, N.H.; Lisacek, F. GlyConnect: Glycoproteomics Goes Visual, Interactive, and Analytical. *J. Proteome Res.* **2019**, *18*, 664–677. [CrossRef] [PubMed]

21. Lombard, V.; Golaconda Ramulu, H.; Drula, E.; Coutinho, P.M.; Henrissat, B. The carbohydrate-active enzymes database (CAZy) in 2013. *Nucleic Acids Res.* **2014**, *42*, D490–D495. [CrossRef] [PubMed]

22. Tiemeyer, M.; Aoki, K.; Paulson, J.; Cummings, R.D.; York, W.S.; Karlsson, N.G.; Lisacek, F.; Packer, N.H.; Campbell, M.P.; Aoki, N.P.; et al. GlyTouCan: An accessible glycan structure repository. *Glycobiology* **2017**, *27*, 915–919. [CrossRef]

23. Mariethoz, J.; Khatib, K.; Alocci, D.; Campbell, M.P.; Karlsson, N.G.; Packer, N.H.; Mullen, E.H.; Lisacek, F. SugarBindDB, a resource of glycan-mediated host-pathogen interactions. *Nucleic Acids Res.* **2016**, *44*, D1243–D1250. [CrossRef]

24. Clerc, O.; Deniaud, M.; Vallet, S.D.; Naba, A.; Rivet, A.; Perez, S.; Thierry-Mieg, N.; Ricard-Blum, S. MatrixDB: Integration of new data with a focus on glycosaminoglycan interactions. *Nucleic Acids Res.* **2019**, *47*, D376–D381. [CrossRef]

25. Bonnardel, F.; Mariethoz, J.; Salentin, S.; Robin, X.; Schroeder, M.; Perez, S.; Lisacek, F.; Imberty, A. UniLectin3D, a database of carbohydrate binding proteins with curated information on 3D structures and interacting ligands. *Nucleic Acids Res.* **2019**, *47*, D1236–D1244. [CrossRef]

26. Lefranc, M.-P.; Giudicelli, V.; Duroux, P.; Jabado-Michaloud, J.; Folch, G.; Aouinti, S.; Carillon, E.; Duvergey, H.; Houles, A.; Paysan-Lafosse, T.; et al. IMGT®, the international ImMunoGeneTics information system® 25 years on. *Nucleic Acids Res.* **2015**, *43*, D413–D422. [CrossRef] [PubMed]

27. Vita, R.; Mahajan, S.; Overton, J.A.; Dhanda, S.K.; Martini, S.; Cantrell, J.R.; Wheeler, D.K.; Sette, A.; Peters, B. The Immune Epitope Database (IEDB): 2018 update. *Nucleic Acids Res.* **2019**, *47*, D339–D343. [CrossRef]

28. Sterner, E.; Flanagan, N.; Gildersleeve, J.C. Perspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource Database. *ACS Chem. Biol.* **2016**, *11*, 1773–1783. [CrossRef] [PubMed]

29. wwPDB Consortium; Burley, S.K.; Berman, H.M.; Bhikadiya, C.; Bi, C.; Chen, L.; Costanzo, L.D.; Christie, C.; Duarte, J.M.; Dutta, S.; et al. Protein Data Bank: The single global archive for 3D macromolecular structure data. *Nucleic Acids Res.* **2019**, *47*, D520–D528. [CrossRef]

30. Sayers, E.W.; Barrett, T.; Benson, D.A.; Bolton, E.; Bryant, S.H.; Canese, K.; Chetvernin, V.; Church, D.M.; DiCuccio, M.; Federhen, S.; et al. Database resources of the National Center for Biotechnology Information. *Nucleic Acids Res.* **2011**, *39*, D38–D51. [CrossRef] [PubMed]

31. Huang, P.; Farkas, T.; Marionneau, S.; Zhong, W.; Ruvoën-Clouet, N.; Morrow, A.L.; Altaye, M.; Pickering, L.K.; Newburg, D.S.; LePendu, J.; et al. Noroviruses Bind to Human ABO, Lewis, and Secretor Histo-Blood Group Antigens: Identification of 4 Distinct Strain-Specific Patterns. *J. Infect. Dis.* **2003**, *188*, 19–31. [CrossRef]

32. Hastings, J.; Owen, G.; Dekker, A.; Ennis, M.; Kale, N.; Muthukrishnan, V.; Turner, S.; Swainston, N.; Mendes, P.; Steinbeck, C. ChEBI in 2016: Improved services and an expanding collection of metabolites. *Nucleic Acids Res.* **2016**, *44*, D1214–D1219. [CrossRef]

33. Kim, S.; Chen, J.; Cheng, T.; Gindulyte, A.; He, J.; He, S.; Li, Q.; Shoemaker, B.A.; Thiessen, P.A.; Yu, B.; et al. PubChem 2019 update: Improved access to chemical data. *Nucleic Acids Res.* **2019**, *47*, D1102–D1109. [CrossRef]

34. Morgat, A.; Lombardot, T.; Axelsen, K.B.; Aimo, L.; Niknejad, A.; Hyka-Nouspikel, N.; Coudert, E.; Pozzato, M.; Pagni, M.; Moretti, S.; et al. Updates in Rhea—An expert curated resource of biochemical reactions. *Nucleic Acids Res.* **2017**, *45*, D415–D418. [CrossRef]

35. Sehnal, D.; Deshpande, M.; Vařeková, R.S.; Mir, S.; Berka, K.; Midlik, A.; Pravda, L.; Velankar, S.; Koča, J. LiteMol suite: Interactive web-based visualization of large-scale macromolecular structure data. *Nat. Methods* **2017**, *14*, 1121–1122. [CrossRef] [PubMed]

36. Alocci, D.; Mariethoz, J.; Horlacher, O.; Bolleman, J.T.; Campbell, M.P.; Lisacek, F. Property Graph vs RDF Triple Store: A Comparison on Glycan Substructure Search. *PLoS ONE* **2015**, *10*, e0144578. [CrossRef]

37. Agravat, S.B.; Saltz, J.H.; Cummings, R.D.; Smith, D.F. GlycoPattern: A web platform for glycan array mining. *Bioinformatics* **2014**, *30*, 3417–3418. [CrossRef] [PubMed]

38. Mehta, A.Y.; Cummings, R.D. GLAD: GLycan Array Dashboard, a visual analytics tool for glycan microarrays. *Bioinformatics* **2019**. [CrossRef]
39. Konishi, Y.; Aoki-Kinoshita, K.F. The GlycomeAtlas tool for visualizing and querying glycome data. *Bioinformatics* **2012**, *28*, 2849–2850. [CrossRef] [PubMed]

40. Sehnal, D.; Grant, O.C. Rapidly Display Glycan Symbols in 3D Structures: 3D-SNFG in LiteMol. *J. Proteome Res.* **2019**, *18*, 770–774. [CrossRef] [PubMed]

41. Varki, A.; Cummings, R.D.; Aebi, M.; Packer, N.H.; Seeberger, P.H.; Esko, J.D.; Stanley, P.; Hart, G.; Darvill, A.; Kinoshita, T.; et al. Symbol Nomenclature for Graphical Representations of Glycans. *Glycobiology* **2015**, *25*, 1323–1324. [CrossRef] [PubMed]

42. Mariethoz, J.; Alocci, D.; Gastaldello, A.; Horlacher, O.; Gasteiger, E.; Rojas-Macias, M.; Karlsson, N.G.; Packer, N.H.; Lisacek, F. Glycomics@ExPASy: Bridging the Gap. *Mol. Cell. Proteom.* **2018**, *17*, 2164–2176. [CrossRef] [PubMed]

43. Stevens, J.; Blixt, O.; Tumpey, T.M.; Taubenberger, J.K.; Paulson, J.C.; Wilson, I.A. Structure and Receptor Specificity of the Hemagglutinin from an H5N1 Influenza Virus. *Science* **2006**, *312*, 404–410. [CrossRef]

44. Raman, R.; Venkataraman, M.; Ramakrishnan, S.; Lang, W.; Raguram, S.; Sasisekharan, R. Advancing glycomics: Implementation strategies at the Consortium for Functional Glycomics. *Glycobiology* **2006**, *16*, 82R–90R. [CrossRef] [PubMed]

45. Jinno, A.; Park, P.W. Role of glycosaminoglycans in infectious disease. *Methods Mol. Biol.* **2015**, *1229*, 567–585. [PubMed]

46. Aquino, R.S.; Park, P.W. Glycosaminoglycans and infection. *Front. Biosci.* **2016**, *21*, 1260–1277.

47. Kim, S.Y.; Zhao, J.; Liu, X.; Fraser, K.; Lin, L.; Zhang, X.; Zhang, F.; Dordick, J.S.; Linhardt, R.J. Interaction of Zika Virus Envelope Protein with Glycosaminoglycans. *Biochemistry* **2017**, *56*, 1151–1162. [CrossRef] [PubMed]

48. Connell, B.J.; Lortat-Jacob, H. Human Immunodeficiency Virus and Heparan Sulfate: From Attachment to Entry Inhibition. *Front. Immunol.* **2013**, *4*, 385. [CrossRef]

49. Ori, A.; Wilkinson, M.C.; Fernig, D.G. A Systems Biology Approach for the Investigation of the Heparin/Heparan Sulfate Interactome. *J. Biol. Chem.* **2011**, *286*, 19892–19904. [CrossRef]

50. Ricard-Blum, S.; Lisacek, F. Glycosaminoglycanomics: Where we are. *Glycoconj. J.* **2017**, *34*, 339–349. [CrossRef] [PubMed]

51. Clerc, O.; Mariethoz, J.; Rivet, A.; Lisacek, F.; Pérez, S.; Ricard-Blum, S. A pipeline to translate glycosaminoglycan sequences into 3D models. Application to the exploration of glycosaminoglycan conformational space. *Glycobiology* **2019**, *29*, 36–44. [CrossRef]

52. Shanker, S.; Czako, R.; Sankaran, B.; Atmar, R.L.; Estes, M.K.; Prasad, B.V.V. Structural Analysis of Determinants of Histo-Blood Group Antigen Binding Specificity in Genogroup I Noroviruses. *J. Virol.* **2014**, *88*, 6168–6180. [CrossRef] [PubMed]

53. Campbell, M.P.; Ranzinger, R.; Lütteke, T.; Mariethoz, J.; Hayes, C.A.; Zhang, J.; Akune, Y.; Aoki-Kinoshita, K.F.; Damerell, D.; Carta, G.; et al. Toolboxes for a standardised and systematic study of glycans. *BMC Bioinform.* **2014**, *15*, S9. [CrossRef] [PubMed]

54. Tsuchiya, S.; Yamada, I.; Aoki-Kinoshita, K.F. GlycanFormatConverter: A conversion tool for translating the complexities of glycans. *Bioinformatics* **2018**. [CrossRef] [PubMed]

55. Herget, S.; Ranzinger, R.; Maass, K.; Lieth, C.-W.V.D. GlycoCT—A unifying sequence format for carbohydrates. *Carbohydr. Res.* **2008**, *343*, 2162–2171. [CrossRef]

56. Uhlen, M.; Fagerberg, L.; Hallstrom, B.M.; Lindskog, C.; Oksvold, P.; Mardinoglu, A.; Sivertsson, A.; Kampf, C.; Sjostedt, E.; Asplund, A.; et al. Tissue-based map of the human proteome. *Science* **2015**, *347*, 1260419. [CrossRef]

57. Ortega, V.; Stone, J.A.; Contreras, E.M.; Iorio, R.M.; Aguilar, H.C. Addicted to sugar: Roles of glycans in the order *Mononegavirales*. *Glycobiology* **2019**, *29*, 2–21. [CrossRef] [PubMed]

<figure><img src="image_11.png" /></figure>